Ji Zhou

Regional co-control plan for local air pollutants and CO2 reduction: Method and practice

An Zeng, Youkai Xing, Tao Hu, 2017 .

Elevated serum thymidine kinase 1 predicts risk of pre/early cancerous progression.

Shouqing Huang, Xia Yun, Ji Zhou, 2011, Asian Pacific journal of cancer prevention : APJCP.

Serum thymidine kinase 1 correlates to clinical stages and clinical reactions and monitors the outcome of therapy of 1,247 cancer patients in routine clinical settings

Xia Yun, Ji Zhou, Ellen He, 2010, International Journal of Clinical Oncology.

Thymidine kinase activity in serum of renal cell carcinoma patients is a useful prognostic marker

Staffan Eriksson, Ji Zhou, Pengcheng Luo, 2009, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Serological thymidine kinase 1 is a prognostic factor in oesophageal, cardial and lung carcinomas

Ning Li, Ji Zhou, Yinghong Wang, 2010, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

The Proliferation Marker Thymidine Kinase 1 Level is High in Normal Kidney Tubule Cells Compared to other Normal and Malignant Renal Cells

Staffan Eriksson, Ji Zhou, Pengcheng Luo, 2010, Pathology & Oncology Research.

Production and characterisation of a novel chicken IgY antibody raised against C-terminal peptide from human thymidine kinase 1.

Qimin He, Ji Zhou, Jianping Wu, 2003, Journal of immunological methods.

Expression of cell proliferating genes in patients with non-small cell lung cancer by immunohistochemistry and cDNA profiling.

Staffan Eriksson, Qimin He, Ji Zhou, 2005, Oncology reports.

Thymidine kinase 1 expression in atypical ductal hyperplasia significantly differs from usual ductal hyperplasia and ductal carcinoma in situ: A useful tool in tumor therapy management.

Staffan Eriksson, Ji Zhou, Ellen He, 2009, Molecular medicine reports.

Serum thymidine kinase 1 concentration as a prognostic factor of chemotherapy-treated non-Hodgkin’s lymphoma patients

Xing-Ying Ji, Ji Zhou, Ellen He, 2010, Journal of Cancer Research and Clinical Oncology.

Serological thymidine kinase 1 (STK1) indicates an elevated risk for the development of malignant tumours.

Ji Zhou, Shenglan Li, Jiyong Hu, 2008, Anticancer research.